GABAA receptor γ2 subunit knockdown mice have enhanced anxiety-like behavior but unaltered hypnotic response to benzodiazepines

BMC Neuroscience

Volumn 6, Issue , 2005, Pages

  Chandra, Dev ^a   Korpi, Esa R ^b   Miralles, Celia P ^c   de Blas, Angel L ^c   Homanics, Gregg E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA 2; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; ALCOHOL; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; MESSENGER RNA; MIDAZOLAM; PHENOBARBITAL; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG; ZOLPIDEM; 4 AMINOBUTYRIC ACID B RECEPTOR; GABRR2 PROTEIN, HUMAN; HYPNOTIC SEDATIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; EXPLORATORY BEHAVIOR; FROZEN SECTION; GENE CASSETTE; GENE EXPRESSION REGULATION; GENE INSERTION; GENE TARGETING; GENETIC VARIABILITY; HETEROZYGOSITY; HYPNOSIS; IMMUNOHISTOCHEMISTRY; INTRON; MAZE TEST; MOUSE; MOUSE MUTANT; NONHUMAN; PHENOTYPE; SYNAPTIC INHIBITION; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; GENETICS; MALE; PHYSIOLOGY;

ANIMALS; ANXIETY; BENZODIAZEPINES; FEMALE; HYPNOTICS AND SEDATIVES; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, GABA-A; RECEPTORS, GABA-B;

EID: 26444444721     PISSN: 14712202     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-6-30     Document Type: Article

References (54)

1. Harris RA, Mihic SJ, Brozowski S, Hadingham K, Whiting PJ: Ethanol, flunitrazepam, and pentobarbital modulation of GABAA receptors expressed in mammalian cells and xenopus oocytes. Alcohol Clin Exp Res 1997, 21:444-451.
2. Homanics GE: Gene targeting strategies in the analysis of alcohol and anesthetic mechanisms. In Genetic Manipulation of Receptor Expression and Function Edited by: Accili D. New York, NY, John Wiley & Sons, Inc.; 2000:93-110.
3. Rudolph U, Crestani F, Mohler H: GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 2001, 22(4):188-194.
4. Rudolph U, Mohler H: Analysis of GABAa receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 2004, 44(1):475-498.
5. DeBlas AL: Brain GABAa receptors studied with subunit-specific antibodies. Mol Neurobiol 1996, 12(1):55-71.
6. Whiting PJ: The GABAA receptor gene family: new opportunities for drug development. Curr Opin Drug Discov Devel 2003, 6(5):648-657.
7. Essrich C, Lorez M, Benson JA, Fritschy JM, Luscher B: Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat Neurosci 1998, 1(7):563-571.
8. Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Kettenmann H, Schofield PR, Seeburg PH: Importance of a novel GABA-A receptor subunit for benzodiazepine pharmacology. Nature 1989, 338:582-585.
9. Gunther U, Benson J, Benke D, Fritschy JM, Reyes G, Knoflach F, Crestani F, Aguzzi A, Arigoni M, Lang Y, Bluethmann H, Mohler H, Luscher B: Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gammaaminobutyric acid type A receptors. Proc Natl Acad Sci U S A 1995, 92(17):7749-7753.
10. Crestani F, Lorez M, Baer K, Essrich C, Benke D, Laurent JP, Belzung C, Fritschy JM, Luscher B, Mohler H: Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 1999, 2(9):833-839.
11. Saijoh Y, Oki S, Ohishi S, Hamada H: Left-right patterning of the mouse lateral plate requires nodal produced in the node. Dev Biol 2003, 256(1):160-172.
12. Ieraci A, Forni PE, Ponzetto C: Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc Natl Acad Sci U S A 2002, 99(23):15200-15205.
13. Raffai RL, Weisgraber KH: Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J Biol Chem 2002, 277(13):11064-11068.
14. Nagy A, Moens C, Ivanyi E, Pawling J, Gertsenstein M, Hadjantonakis AK, Pirity M, Rossant J: Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. Curr Biol 1998, 8(11):661-664.
15. Meyers EN, Lewandoski M, Martin GR: An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 1998, 18(2):136-141.
16. Mohn AR, Gainetdinov RR, Caron MG, Koller BH: Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999, 98(4):427-436.
17. Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers EN: Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 2002, 129(19):4613-4625.
18. Althini S, Bengtsson H, Usoskin D, Soderstrom S, Kylberg A, Lindqvist E. Chuva de Sousa Lopes S, Olson L, Lindeberg J, Ebendal T: Normal nigrostriatal innervation but dopamine dysfunction in mice carrying hypomorphic tyrosine hydroxylase alleles. J Neurosci Res 2003, 72(4):444-453.
19. Liu Y, Festing MH, Hester M, Thompson JC, Weinstein M: Generation of novel conditional and hypomorphic alleles of the Smad2 gene. Genesis 2004, 40(2):118.
20. Martin DM, Skidmore JM, Philips ST, Vieira C, Gage PJ, Condie BG, Raphael Y, Martinez S, Camper SA: PITX2 is required for normal development of neurons in the mouse subthalamic nucleus and midbrain. Dev Biol 2004, 267(1):93-108.
21. Rucker EB, Dierisseau P, Wagner KU, Garrett L, Wynshaw-Boris A, Flaws JA, Hennighausen L: Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol 2000, 14(7):1038-1052.
22. Tian E, Kimura C, Takeda N, Aizawa S, Matsuo I: Otx2 is required to respond to signals from anterior neural ridge for forebrain specification. Dev Biol 2002, 242(2):204-223.
23. Wu L, Gu J, Cui H, Zhang QY, Behr M, Fang C, Weng Y, Kluetzman K, Swiatek PJ, Yang W, Kaminsky L, Ding X: Transgenic Mice with a Hypomorphic NADPH-Cytochrome P450 Reductase Gene: Effects on Development, Reproduction, and Microsomal Cytochrome P450. J Pharmacol Exp Ther 2005, 312:35-43.
24. Lewandoski M, Meyers EN, Martin GR: Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb Symp Quant Biol 1997, 62:159-168.
25. Schweizer C, Balsiger S, Bluethmann H, Mansuy IM, Fritschy JM, Mohler H, Luscher B: The gamma 2 subunit of GABA(A) receptors is required for maintenance of receptors at mature synapses. Mol Cell Neurosci 2003, 24(2):442-450.
26. Cope DW, Wulff P, Oberto A, Aller MI, Capogna M, Ferraguti F, Halbsguth C, Hoeger H, Jolin HE, Jones A, McKenzie AN, Ogris W, Poeltl A, Sinkkonen ST, Vekovischeva OY, Korpi ER, Sieghart W, Sigel E, Somogyi P, Wisden W: Abolition of zolpidem sensitivity in mice with a point mutation in the GABA(A) receptor gamma2 subunit. Neuropharmacology 2004, 47(1):17-34.
27. Leppa E, Vekovischeva OY, Linden AM, Wulff P, Oberto A, Wisden W, Korpi ER: Agonistic effects of the beta-carboline DMCM revealed in GABA(A) receptor gamma2 subunit F77I pointmutated mice. Neuropharmacology 2005, 48(4):469-478.
28. Homanics GE, Harrison NL, Quinlan JJ, Krasowski MD, Rick CEM, deBlas AL, Mehta A, Kist F, Mihalek RM, Aul JJ, Firestone LL: Normal electrophysiological and behavioral responses to ethanol in mice lacking the long splice variant of the g2 subunit of the g-aminobutyrate type A receptor. Neuropharmacology 1999, 38(2):253-265.
29. Baer K, Essrich C, Balsiger S, Wick MJ, Harris RA, Fritschy JM, Luscher B: Rescue of gamma2 subunit-deficient mice by transgenic overexpression of the GABAA receptor gamma2S or gamma2L subunit isoforms. European Journal of Neuroscience 2000, 12(7):2639-2643.
30. Sigel E: Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2002, 2(8):833-839.
31. Sinkkonen ST, Luscher B, Luddens H, Korpi ER: Autoradiographic imaging of altered synaptic alphabetagamma2 and extrasynaptic alphabeta GABAA receptors in a genetic mouse model of anxiety. Neurochem Int 2004, 44(7):539-547.
32. Korpi ER, Mihalek RM, Sinkkonen ST, Hauer B, Hevers W, Homanics GE, Sieghart W, Lüddens H: Altered receptor subtypes in the forebrain of GABAA receptor d subunit-deficient mice: recruitment of g2 subunits. Neuroscience 2002, 109:733-743.
33. Lorez M, Benke D, Luscher B, Mohler H, Benson JA: Single-channel properties of neuronal GABAA receptors from mice lacking the gamma2 subunit. J Physiol 2000, 527:11-31.
34. Abadie P, Rioux P, Scatton B, Zarifian E, Barre L, Patat A, Baron JC: Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography. Eur J Pharmacol 1996, 295(1):35-44.
35. Sybirska E, Seibyl JP, Bremner JD, Baldwin RM, al-Tikriti MS, Bradberry C, Malison RT, Zea-Ponce Y, Zoghbi S, During M, Goddard AW, Woods SW, Hoffer PB, Charney DS, Innis RB: [123I]iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain. Neuropharmacology 1993, 32(7):671-680.
36. Low K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U: Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290(5489):131-134.
37. Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Mohler H: Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999, 401(6755):796-800.
38. McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ: Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 2000, 3(6):587-592.
39. Lindquist CE, Ebert B, Birnir B: Extrasynaptic GABA(A) channels activated by THIP are modulated by diazepam in CA1 pyramidal neurons in the rat brain hippocampal slice. Mol Cell Neurosci 2003, 24(1):250-257.
40. Kralic JE, O'Buckley TK, Khisti RT, Hodge CW, Homanics GE, Morrow AL: GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem. Neuropharm 2002, 43(4):685-694.
41. Kralic JE, Korpi ER, O'Buckley TK, Homanics GE, Morrow AL: Molecular and pharmacological characterization of GABA(A) receptor alpha1 subunit knockout mice. J Pharmacol Exp Ther 2002, 302(3):1037-1045.
42. Quinlan JJ, Firestone LL, Homanics GE: Mice lacking the long splice variant of the g2 subunit of the GABAa receptor are more sensitive to benzodiazepines. Pharmacol Biochem Behav 2000, 66(2):371-374.
43. Quinlan JJ, Homanics GE, Firestone LL: Anesthesia sensitivity in mice that lack the beta3 subunit of the gamma-aminobutyric acid type A receptor. Anesthesiology 1998, 88(3):775-780.
44. Tybulewicz VLJ, Crawford CE, Jackson PK, Bronson RT, Mulligan RC: Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 1991, 65:1153-1163.
45. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC: Derivation of completely cell culture-derived mice from earlypassage embryonic stem cells. Proc Natl Acad Sci, U S A 1993, 90:8424-8428.
46. Homanics GE, Ferguson C, Quinlan JJ, Daggett J, Snyder K, Lagenaur C, Mi ZP, Wang XH, Grayson DR, Firestone LL: Gene knockout of the alpha-6 subunit of the gamma-aminobutyric acid type A receptor: Lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol 1997, 51(4):588-596.
47. de Blas AL, Vitorica J, Friedrich P: Localization of the GABAA receptor in the rat brain with a monoclonal antibody to the 57,000 Mr peptide of the GABAA receptor/benzodiazepine receptor/Cl- channel complex. J Neurosci 1988, 8(2):602-614.
48. Christie SB, Li RW, Miralles CP, Riquelme R, Yang BY, Charych E, Wendou Y, Daniels SB, Cantino ME, De Blas AL: Synaptic and extrasynaptic GABAA receptor and gephyrin clusters. Prog Brain Res 2002, 136:157-180.
49. Christie SB, Miralles CP, De Blas AL: GABAergic innervation organizes synaptic and extrasynaptic GABAA receptor clustering in cultured hippocampal neurons. J Neurosci 2002, 22(3):684-697.
50. Miralles CP, Li M, Mehta AK, Khan ZU, De Blas AL: Immunocytochemical localization of the beta(3) subunit of the gammaaminobutyric acid(A) receptor in the rat brain. J Comp Neurol 1999, 413(4):535-548.
51. Mäkelä R, Uusioukari M, Homanics GE, Quinlan JJ, Firestone LL, Wisden W, Korpi ER: Cerebellar gamma-aminobutyric acid type a receptors: Pharmacological subtypes revealed by mutant mouse lines. Mol Pharmacol 1997, 52(3):380-388.
52. Lüddens H, Pritchett DB, Kohler M, Killisch I, Keinanen K, Monyer H, Sprengel R, Seeburg PH: Cerebellar GABA-A receptor selective for a behavioural alcohol antagonist. Nature 1990, 346:648-651.
53. Wisden W, Herb A, Wieland H, Keinänen K, Lüddens H, Seeberg PH: Cloning, pharmacological characteristics and expression pattern of the GABAA receptor a4 subunit. FEBS Lett 1991, 289(2):227-230.
54. Pritchett DB, Seeburg PH: g-aminobutyric acid-A receptor a5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem 1990, 54(5):1802-1805.